Company Atlasby Kadoa
Star on GitHub

ResMed RMD

ResMed is the 287th largest S&P 500 company by market cap, worth $36.5 billion. 11 directors have filed with the SEC in the last 12 months (who counts), 1 of them an executive. 4 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 13.0% of the company.

Chair and CEO
Michael J. Farrell
Sector
Health Care
Sub-industry
Health Care Equipment
Headquarters
San Diego, California
Founded
1989
More
Wikipedia
Market cap
$36.5B
287th largest, 23 Oct 2026 close
Revenue
$5.7B
Fiscal year 2026
Price to sales
6.5
Market cap over revenue
Employees
11,370
10-K, 30 Jun 2026
Market cap per employee
$3.2M
Market cap over employees
Connections
3
S&P 500 companies sharing a director or officer

Largest institutional holders

Each fund group's share of ResMed. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 32.0% of ResMed.

Source: SEC Form 13F data sets, SEC XBRL shares outstanding 路 All holders

Board and officers

3 people here also hold roles at other S&P 500 companies.

Roles filed up to 30 Sep 2026

NameTitle
Directors (11)
Michael J. FarrellChairman and CEOAlso at Zimmer BiometChairman and CEO
Carol BurtDirectorAlso at IQVIALast filed 24 Nov 2025Director
Christopher DelOreficeDirectorAlso at Ulta BeautyLast filed 24 Nov 2025Director
Karen DrexlerDirectorLast filed 24 Nov 2025Director
Peter C. FarrellDirectorDirector
Harjit GillDirectorLast filed 24 Nov 2025Director
John HernandezDirectorLast filed 24 Nov 2025Director
Nicole Mowad-NassarDirectorLast filed 26 Nov 2025Director
Desney TanDirectorLast filed 24 Nov 2025Director
Ronald R. TaylorDirectorLast filed 24 Nov 2025Director
Jan De WitteDirectorLast filed 26 Nov 2025Director
Officers (4)
Aaron BloomerChief Financial OfficerLast filed 4 May 2026Chief Financial Officer
Brett SandercockChief Financial OfficerLast filed 4 May 2026Chief Financial Officer
Justin LeongChief Product OfficerLast filed 24 Nov 2025Chief Product Officer
Michael J. RiderGlobal General CounselLast filed 3 Jun 2026Global General Counsel

Source: SEC insider filings (Forms 3, 4 and 5), ResMed's Form 4 filings 路 All directors and officers

Companies that share people with ResMed

Each person's title here, then at the other company.

  • IQVIA IQV
    • Carol Burt: Director here, Director there
  • Ulta Beauty ULTA
    • Christopher DelOrefice: Director here, Chief Financial Officer there
  • Zimmer Biomet ZBH
    • Michael J. Farrell: Chairman and CEO here, Director there

Source: SEC insider filings 路 See the whole network

ResMed's market cap since December 2008

Marked weeks are changes in the share count, such as a merger, not market moves.

Weekly, up to 23 Oct 2026

Show equal percentage changes as equal steps.
201020122014201620182020202220242026$36.5B

Source: Yahoo Finance closing prices, SEC XBRL shares outstanding

Workforce

Headcount at 30 Jun 2026

Employees
11,370
As of June 30, 2026, we had approximately 11,370 employees, of which approximately 4,590 were employed in cost of sales activities including areas such as warehousing and manufacturing, 2,300 in research and development and 4,480 in sales, marketing and administration.
ResMed Form 10-K

Source: ResMed Form 10-K

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 30 Sep 2025 to 30 Sep 2026

Directors and officers sold $24.2 million of stock in 33 sales and made no open-market purchases in the 12 months to 30 Sep 2026.

DatePersonTitleTypeSharesValue
8 Sep 2026SaleMichael J. FarrellChairman and CEOChairman and CEOSale4,991$1.1M
2 Sep 2026SalePeter C. FarrellDirectorDirectorSale970$228K
7 Aug 2026SaleMichael J. FarrellChairman and CEOChairman and CEOSale4,991$1.0M
5 Aug 2026SalePeter C. FarrellDirectorDirectorSale8,000$1.8M
7 Jul 2026SaleMichael J. FarrellChairman and CEOChairman and CEOSale4,991$1.1M
8 Jun 2026SaleMichael J. FarrellChairman and CEOChairman and CEOSale4,991$968K
7 May 2026SaleMichael J. FarrellChairman and CEOChairman and CEOSale4,991$1.0M
7 Apr 2026SaleMichael J. FarrellChairman and CEOChairman and CEOSale4,991$1.1M
1 Apr 2026SalePeter C. FarrellDirectorDirectorSale2,000$450K
1 Apr 2026SaleBrett SandercockChief Financial OfficerChief Financial OfficerSale1,000$224K

Showing 10 of 33 trades

Source: SEC insider transactions data sets, ResMed's Form 4 filings

Trades by members of Congress and officials

Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.

Trades from 20 Oct 2023 to 20 Oct 2026

6 people disclosed 13 purchases and 15 sales of ResMed stock since October 2023.

DateMember or officialTypeAmount
11 Sep 2026Rohit Khanna (House, D-CA)House, D-CA 路 BoughtPurchase$1,001 to $15,000$1K to $15K
23 Jun 2026Donald J Trump (President)President 路 BoughtPurchase$1,001 to $15,000$1K to $15K
3 Jun 2026Donald J Trump (President)President 路 BoughtPurchase$1,001 to $15,000$1K to $15K
22 May 2026Donald J Trump (President)President 路 BoughtPurchase$50,001 to $100,000$50K to $100K
18 May 2026Donald J Trump (President)President 路 SoldSale$1,001 to $15,000$1K to $15K
11 May 2026Donald J Trump (President)President 路 SoldSale$15,001 to $50,000$15K to $50K
28 Apr 2026Donald J Trump (President)President 路 SoldSale$1,001 to $15,000$1K to $15K
27 Apr 2026Donald J Trump (President)President 路 BoughtPurchase$15,001 to $50,000$15K to $50K
13 Apr 2026Rohit Khanna (House, D-CA)House, D-CA 路 BoughtPurchase$1,001 to $15,000$1K to $15K
27 Mar 2026Alan Armstrong (Senate, R-OK)Senate, R-OK 路 BoughtPurchase$1,001 to $15,000$1K to $15K

Showing 10 of 28 trades

Source: House, Senate and OGE disclosures via the Congress trading monitor

Not on file: no WARN layoff notices under its own name since October 2023.